Join us at the 2nd Donor Selection & Cell Source Summit - an unparalleled event dedicated to revolutionizing donor testing, screening, and cell source selection. This is your chance to […]

The landmark FDA approval of the first MASH therapeutic, the orphan drug designation for systemic sclerosis trials, and the rapid advancement of IPF treatments through clinical phases have ignited a […]

Mark your calendars for November because LEAP HR: Emerging Biopharma is back! Returning to Boston from November 19-20, this event is designed specifically for CHROs, CPOs, and Heads of HR […]